DE1670648C3 - Phenyläthylbarbiturat des 1lsopropylamino-3- (1 -naphtyloxy) propan-2-ols - Google Patents

Phenyläthylbarbiturat des 1lsopropylamino-3- (1 -naphtyloxy) propan-2-ols

Info

Publication number
DE1670648C3
DE1670648C3 DE1670648A DE1670648A DE1670648C3 DE 1670648 C3 DE1670648 C3 DE 1670648C3 DE 1670648 A DE1670648 A DE 1670648A DE 1670648 A DE1670648 A DE 1670648A DE 1670648 C3 DE1670648 C3 DE 1670648C3
Authority
DE
Germany
Prior art keywords
propranolol
isopropylamino
propan
naphtyloxy
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1670648A
Other languages
German (de)
English (en)
Other versions
DE1670648A1 (de
DE1670648B2 (de
Inventor
Francis Alain Paris Langlume
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nativelle SA Ets
Original Assignee
Nativelle SA Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nativelle SA Ets filed Critical Nativelle SA Ets
Publication of DE1670648A1 publication Critical patent/DE1670648A1/de
Publication of DE1670648B2 publication Critical patent/DE1670648B2/de
Application granted granted Critical
Publication of DE1670648C3 publication Critical patent/DE1670648C3/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • C07D239/62Barbituric acids
    • C07D239/64Salts of organic bases; Organic double compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DE1670648A 1967-01-16 1968-01-15 Phenyläthylbarbiturat des 1lsopropylamino-3- (1 -naphtyloxy) propan-2-ols Expired DE1670648C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR91205A FR6230M (US20090192370A1-20090730-C00001.png) 1967-01-16 1967-01-16

Publications (3)

Publication Number Publication Date
DE1670648A1 DE1670648A1 (de) 1972-04-27
DE1670648B2 DE1670648B2 (de) 1974-07-04
DE1670648C3 true DE1670648C3 (de) 1975-02-13

Family

ID=8623890

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1670648A Expired DE1670648C3 (de) 1967-01-16 1968-01-15 Phenyläthylbarbiturat des 1lsopropylamino-3- (1 -naphtyloxy) propan-2-ols

Country Status (8)

Country Link
US (1) US3798221A (US20090192370A1-20090730-C00001.png)
BE (1) BE709223A (US20090192370A1-20090730-C00001.png)
CH (1) CH472411A (US20090192370A1-20090730-C00001.png)
DE (1) DE1670648C3 (US20090192370A1-20090730-C00001.png)
ES (1) ES349774A1 (US20090192370A1-20090730-C00001.png)
FR (1) FR6230M (US20090192370A1-20090730-C00001.png)
GB (1) GB1189782A (US20090192370A1-20090730-C00001.png)
NL (1) NL6800585A (US20090192370A1-20090730-C00001.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201318659D0 (en) * 2013-10-22 2013-12-04 Ucl Business Plc Beta-catenin

Also Published As

Publication number Publication date
US3798221A (en) 1974-03-19
DE1670648A1 (de) 1972-04-27
NL6800585A (US20090192370A1-20090730-C00001.png) 1968-07-17
GB1189782A (en) 1970-04-29
CH472411A (fr) 1969-05-15
FR6230M (US20090192370A1-20090730-C00001.png) 1968-08-05
ES349774A1 (es) 1969-04-01
BE709223A (US20090192370A1-20090730-C00001.png) 1968-05-16
DE1670648B2 (de) 1974-07-04

Similar Documents

Publication Publication Date Title
DE1670827C3 (de) 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2904445C2 (de) N↓1↓-(4-Amino-6.7-dimethoxy-2-chinazolyl)-N↓1↓-methyl-N↓2↓-(2-tetrahydrofuroyl)-1.3-propandiamin, seine Herstellung und seine pharmazeutische Verwendung
DE1294955B (de) 1-(o-Allylphenoxy)- und 1-(p-Allyl-phenoxy)-2-hydroxy-3-isopropylaminopropan und Verfahren zu deren Herstellung
DE3505359A1 (de) Arzneimittel zur behandlung von akuter, myocardialer ischaemie
CH649545A5 (de) Arzneimittel gegen theileriosen.
DE3129750A1 (de) 5'-aminoalkyl-4',4,8-trialkylpsoralene
DE1670572C3 (de) Cinnamylpiperazine und ihre Hydrochloride, Verfahren zu ihrer Herstellung und Arzneimittel
DE2403122C2 (US20090192370A1-20090730-C00001.png)
DE3234537C2 (de) Verwendung von 3-(2,2,2-Trimethylhydrazinium)propionatdihydrat zur Behandlung kardiovaskulärer Erkrankungen
DE1670648C3 (de) Phenyläthylbarbiturat des 1lsopropylamino-3- (1 -naphtyloxy) propan-2-ols
EP0005732B1 (de) Verwendung von 2-Amino-oxazolo- oder 2-Amino-thiazolo-[5,4-d]azepinen sowie deren Säureadditionssalzen zur Herstellung eines Arzneimittels für die Verwendung bei der Bekämpfung von Angina Pectoris
DE3205149C2 (US20090192370A1-20090730-C00001.png)
EP0342565B1 (de) Verwendung des Thiazol-Derivates Tiprotimod zur Herstellung eines Mittels zur Therapie von Virusinfektionen
DD283931A5 (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von herzrhythmusstoerungen
DE2336560C2 (de) Arzneimittel, enthaltend l-(2-Hydroxy-2-indanyl)-propylamin
DE2521905C2 (de) Arzneimittel zur cerebralen Durchblutungsförderung
DE2314387C3 (de) Arzneimittel zur Behandlung bösartiger Neubildungen
DE2645873C3 (de) Ajmalinderivate und ein Verfahren zu deren Herstellung
DE2014201C3 (de) Hydrochlorid des 10-(beta-morpholinopropionyl)-phenothiazin-2-carbamin-saeureaethylesters, verfahren zu dessen herstellung und pharmazeutisches mittel
DE1915795C3 (de) N- (3,4,5-Trimethoxycinnamoyl) -N'- (carbonylmethyl) -piperazinderivate und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT268247B (de) Verfahren zur Herstellung von neuen 1-Isopropylamino-2-hydroxy-3-(alkenylphenoxy)-propanen und deren Salzen
DE2417638C3 (de) 2-Methyl-3-carbäthoxy-4-chlor-5hydroxy-6-dimethylaminomethylbenzofuran und dessen pharmakologisch verträgliche Salze sowie Arzneimittel mit einem Gehalt dieser Verbindungen
AT390559B (de) Verwendung von neuen, psoralenfreien 6-methyl-angelicinen bzw. von deren salzen fuer die herstellung von arzneimitteln
DE1470151C (de) Heterocyclische Amme und Verfahren zu ihrer Herstellung
AT358009B (de) Verfahren zur herstellung von neuen 2-(4- hydroxy-3-(alkylthio-, alkylsulfinyl- oder alkylsulfonyl) phenyl)-aethylaminen, deren estern und salzen

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)